San Francisco, California 94111
is a partner with King & Spalding’s FDA & Life Sciences Practice Group.
After prior practice with the group as an associate and partner-elect, Ms. Tseng rejoined the group following service as Regulatory Counsel at the Food and Drug Administration, where she received the Department of Health and Human Services Secretary’s Award for Distinguished Service and other FDA honors. In her practice, Ms. Tseng advises medical device, pharmaceutical, and biotechnology companies on a variety of FDA approval, compliance, and enforcement matters.
Ms. Tseng has been invited to speak on topics of FDA regulation for groups including the American Conference Institute (ACI), the Advanced Medical Technology Association (AdvaMed), the Biotechnology Industry Organization (BIO), and the Center for Business Intelligence (CBI). She received her law degree from Harvard Law School and her undergraduate degrees from Cornell University.
|Areas of Practice||1) FDA & Life Sciences , 2) Health IT and EHRs , 3) Healthcare Litigation and 4) Emerging Growth|
|Law School||J.D., Harvard University|
|Education||B.A., magna cum laude, Cornell University|
|Bar Member / Association||State bar of California,State bar of District of Columbia,State bar of Texas|
|Most recent firm||King & Spalding LLP|
Ms. Fitzgerald represents employers in a wide range of industries, including the entertainment, financial services, hospitality, manufacturing, retail, and transportation industries.
Ms. Shander advises public and private company clients as well as private equity funds, with an emphasis on mergers and acquisitions, dispositions, and financing transactions.